• Email Us: [email protected]
  • Contact Us: +1 718 874 1545
  • Skip to main content
  • Skip to primary sidebar

Medical Market Report

  • Home
  • All Reports
  • About Us
  • Contact Us

The New Universal Flu Vaccine Scientists Say Could Be Ready In “Five Years Or Less”

July 20, 2024 by Deborah Bloomfield

A vaccine platform that promises a one-shot solution to the flu has just been tested on a potential pandemic strain, and the scientists behind it say their results are very promising indeed.

Advertisement

“I think it means within five to 10 years, a one-and-done shot for influenza is realistic,” said corresponding author Jonah Sacha of Oregon Health & Science University in a statement.

A flu vaccine that could negate the need for annual booster shots – and absolve scientists of the task of predicting which strains are going to dominate each season – has always been up there with the biggest research goals of modern medicine. Lots of different approaches are in development, from a vaccine mixed from 80,000 proteins, to ones that leverage the mRNA technology that saw such success against COVID-19.

This time, the scientists have reworked a vaccine platform that they’re also using to try and target tuberculosis and HIV, with the HIV candidate already in clinical trials. The platform uses a vector – another virus that doesn’t cause serious disease in humans, but can be used as a carrier for the pathogen that you want to vaccinate against.

In this case, that carrier is cytomegalovirus (CMV). Most of us will be infected with it in our lifetimes, with few to no symptoms. The scientists engineered the virus to contain small pieces of an infamous influenza strain – the one responsible for the 1918 pandemic, often (incorrectly) nicknamed the “Spanish flu”.

Transmission electron micrograph of cytomegalovirus (CMV) particles (purple) found within intracellular vesicles of an infected macrophage (blue)

Purple cytomegalovirus particles, captured in this microscope image inside an infected macrophage (a type of white blood cell).

The team vaccinated 11 Mauritian cynomolgus macaque monkeys, before exposing them to a strain of flu that’s much more up to date: avian H5N1, which is currently circulating in US dairy cows as well as hitting other mammal species around the world.

Advertisement

Six of the 11 monkeys survived the exposure to H5N1, a notoriously deadly flu strain. That’s despite the fact that the strain the vaccine was actually based on predates it by almost a century.

“It worked because the interior protein of the virus was so well preserved,” Sacha explained. “So much so, that even after almost 100 years of evolution, the virus can’t change those critically important parts of itself.”

This is the crux of why this study is potentially so exciting. It holds the promise of a vaccine targeting the parts of the flu virus that remain conserved over long periods of time, even while it’s rearranging and mutating itself so efficiently that we can never quite know when a strain with pandemic potential will come along.

Experts have been warning of the potential consequences of bird flu making a sustained jump into the human population. Quite apart from the fact that we’re not even done with the last pandemic we had to face, an H5N1 strain adapted to spread between people could cause devastating disease outbreaks if not controlled.

Advertisement

“Inhalation of aerosolized H5N1 influenza virus causes a cascade of events that can trigger respiratory failure,” said co-author Dr Simon Barratt-Boyes of the University of Pittsburgh. “The immunity induced by the vaccine was sufficient to limit virus infection and lung damage, protecting the monkeys from this very serious infection.”

Hopefully, an updated CMV-based vaccine for humans could do the same for us.

More research and clinical trials will clearly be required before any such vaccine can be marketed, but the scientists are optimistic that the timelines involved might be shorter than you would think. Rather than decades, Sacha believes we could be looking at “five years or less” – and not only for the flu.

“For viruses of pandemic potential, it’s critical to have something like this. We set out to test influenza, but we don’t know what’s going to come next,” he said, adding, “It’s a very viable approach.”

Advertisement

No more yearly flu shots? A potential defence against the next pandemic? Can we dare to hope that we’re finally reaching these goals? Maybe.

“It’s a massive sea change within our lifetimes,” Sacha concluded. “There is no question we are on the cusp of the next generation of how we address infectious disease.”

The study is published in Nature Communications.

Deborah Bloomfield
Deborah Bloomfield

Related posts:

  1. China vehicle sales slid 18% in August – industry body
  2. Fed’s Powell: Reopening economic bottlenecks could be “more enduring”
  3. The World’s Oldest Bottle Of Wine Might Actually Be Safe To Drink
  4. How Coffee Could Protect Against Alzheimer’s: Espresso Found To Inhibit Tau Proteins

Source Link: The New Universal Flu Vaccine Scientists Say Could Be Ready In “Five Years Or Less”

Filed Under: News

Primary Sidebar

  • DNA From Greenland Sled Dogs – Maybe The World’s Oldest Breed – Reveals 1,000 Years Of Arctic History
  • Why Doesn’t Moonrise Shift By The Same Amount Each Night?
  • Moa De-Extinction, Fashionable Chimps, And Robot Surgery – No Human Required
  • “Human”: Powerful New Images Mark The Most Scientifically Accurate “Hyper-Real 3D Models Of Human Species Ever”
  • Did We Accidentally Leave Life On The Moon In 2019 – And Could We Revive It?
  • 1.8 Million Years Ago, Two Extinct Humans Had One Of The Gnarliest Deaths In History
  • “Powerful Image” Of One Of The World’s Rarest Tigers Exposes The Real Danger In Taman Negara
  • Evolution, Domestication, And A Lot Of Very Good Boys: How Wolves Became Dogs
  • Why Do Orcas Have White Spots Near Their Eyes?
  • Tomb Of First King Of Ancient Maya City Discovered In Belize
  • The Real Reason The Tip Of Your Tape Measure Wiggles Like That
  • The “Haunting” Last Message From NASA’s Opportunity Rover, Sent From Inside A Planet-Wide Storm
  • Adorable Video Proves Not All Gorillas Hate The Rain. It Might Even Win One A Mate
  • 5,000-Year-Old Rock Art May Show One Of Ancient Egypt’s First Rulers
  • Alzheimer’s-Linked Protein Levels “20 Times Higher” In Newborn Babies – What Does This Mean?
  • Americans Were Asked If They Thought Civil War Was Coming. The Results Were Unexpected
  • Voyager 1 & 2 Could Be Detected From Almost A Light-Year Away With Our Current Technology
  • Dams Have Nudged Earth’s Poles By Over 1 Meter In The Past 200 Years
  • This Sugar Could Be A Cure For Male Pattern Baldness – And It’s Been In Our Bodies All Along
  • “Cosmic Immigrants”: Daytime Star Seen In 1604 May Be An “Alien Type Ia Supernova”
  • Business
  • Health
  • News
  • Science
  • Technology
  • +1 718 874 1545
  • +91 78878 22626
  • [email protected]
Office Address
Prudour Pvt. Ltd. 420 Lexington Avenue Suite 300 New York City, NY 10170.

Powered by Prudour Network

Copyrights © 2025 · Medical Market Report. All Rights Reserved.

Go to mobile version